Profile
Dr Nithia Angamuthu graduated from University of Newcastle, United Kingdom with MBBS, Honours (Distinction) in 2009, during which she also completed an intercalated degree in BSc Genetics (1st Deg Hons). She obtained MRCP UK in 2013 before completing SingHealth Advanced Internal Medicine Senior Residency in 2018. She completed Advanced Specialist Training in Palliative Medicine in 2020.
Education
- Specialist Certificate in Acute Medicine, United Kingdom, Royal Colleges of Physicians, 2017
- Membership of Royal Colleges of Medicine, United Kingdom, Royal Colleges of Physicians, 2013
- Bachelor of Medicine, Bachelor of Surgery, United Kingdom, University of Newcastle, 2009
- Bachelor of Science (Genetics) 1st deg Hons, United Kingdom, University of Newcastle, 2006
View More +
Professional Appointments and Committee Memberships
View More +
Awards
- Highly Commendable Abstract at 14th Asia Pacific Hospice Palliative Care Conference 2021
- SingHealth Residency in SingHealth Excels RiSE awards 2013
View More +
Publications
- Surveys of Stroke Patients and Their Next of Kin on Their Opinions Towards Decision-Making and Consent for Stroke Thrombolysis. Nithia Angamuthu, Kian Kheng Queck, Sumytra Menon, Shu Swen Ho, Elaine Ang, Deidre Anne De Silva. Ann Acad Med Singapore 46(2), 50-63. Feb 2017
- Rare breast malignancies and review of literature: A single centre experience. Ng CE, Angamuthu N, Fasih T. Int J Surg Case Rep. 2015;11:11-7
- Primary breast osteosarcoma: a case report and review of literature. Al Samaraee A, Angamuthu N, Fasih T. Scott Med J. 2014 Nov;59(4)
- Evaluation of enteropathy-associated T-cell lymphoma comparing standard therapies with a novel regimen including autologous stem cell transplantation. Sieniawski M, Angamuthu N, Boyd K, Chasty R, Davies J, Forsyth P, Jack F, Lyons S, Mounter P, Revell P, Proctor SJ, Lennard AL. Blood. 2010 May 6;115(18):3664-70.
- Sequential evaluation of outcome in enteropathy associated T cell lymphoma comparing standard therapeutic approaches–surgery or CHOP-like chemotherapy with a new high dose ifosfamide/methotrexate and autologous stem cell transplant regimen: A prospective study of Scotland and Newcastle lymphoma group. Michal Sieniawski, Nithia Angamuthu, Kathryn Boyd, Richard Chasty, John Davies, Paul Revell, Stephen J Proctor, Anne L Lennard. Blood, The Journal of the American Society of Hematology. 2008. 112 (11), 578-578
View More +
